2014
DOI: 10.1007/978-1-4939-0345-0_20
|View full text |Cite
|
Sign up to set email alerts
|

Loading of Acute Myeloid Leukemia Cells with Poly(I:C) by Electroporation

Abstract: In this chapter, we describe the technique of electroporation as an efficient method to load primary leukemic cells with the double-stranded RNA (dsRNA) analogue, polyriboinosinic polyribocytidylic acid (poly(I:C)), and detail on the delicate freezing and thawing procedure of primary leukemic cells.Electroporation is a non-viral gene transfer method by which short-term pores in the membrane of cells are generated by an electrical pulse, allowing molecules to enter the cell. RNA electroporation, a technique dev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…In the late stages of apoptosis, nuclei fragment and condense to form distinct apoptotic bodies (Gregory and Devitt, 2004). It is possible that the reported increase in the immunogenicity of poly I:C-electroporated leuke mic cells (Lion et al, 2009(Lion et al, , 2011(Lion et al, , 2014Smits et al, 2007) is not solely due to recognition of apoptotic tu mour cells, but could potentially be a response to ne crotic tumour cells. The decision of antigenpresenting cells, such as DCs, to mount an immunogenic or tolero genic adaptive immune response against internalized material has strong implications in devising the most ap propriate immunotherapeutic treatment for leukemic diseases such as AML.…”
Section: Resultsmentioning
confidence: 99%
“…In the late stages of apoptosis, nuclei fragment and condense to form distinct apoptotic bodies (Gregory and Devitt, 2004). It is possible that the reported increase in the immunogenicity of poly I:C-electroporated leuke mic cells (Lion et al, 2009(Lion et al, , 2011(Lion et al, , 2014Smits et al, 2007) is not solely due to recognition of apoptotic tu mour cells, but could potentially be a response to ne crotic tumour cells. The decision of antigenpresenting cells, such as DCs, to mount an immunogenic or tolero genic adaptive immune response against internalized material has strong implications in devising the most ap propriate immunotherapeutic treatment for leukemic diseases such as AML.…”
Section: Resultsmentioning
confidence: 99%